ARTICLE SUMMARY:
Medtronic and Edwards lead in transcatheter pulmonary valve replacement, a small market with tremendous unmet need; emerging players in focused ultrasound, a fertile area for medical device innovation; developing minimal residual disease biomarkers for cancer; activist investor Elliott Investment Management takes a big stake in Medtronic; and from Outcome Capital: understanding buyer risk to maximize value for both parties in M&A deals.
